WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells

J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.

Abstract

Backgrounds: Emerging evidence has demonstrated that WISP2 is critically involved in cell proliferation, migration, invasion and metastasis in cancers. However, the function of WISP2 in esophageal squamous cell carcinoma (ESCC) is largely unclear. Therefore, we aim to explore the effects and the potential mechanism of WISP2 on proliferation and motility and invasion of ESCC cells.

Methods: Cell proliferation was detected by MTT assay and apoptosis was measured by FACS in ESCC cells after WISP2 downregulation and overexpression. Cell migration and invasion were analyzed by wound healing assay and transwell migration assay, respectively. The expression of ERK-1/2, Slug and E-cadherin was measured by Western blot respectively. IHC was performed to measure the expression of WISP2 in ESCC tissues.

Results: WISP2 overexpression is associated with survival in ESCC patients. WISP2 overexpression inhibited cell growth and induced cell apoptosis, suppressed cell migration and invasion in ESCC cells. Moreover, WISP overexpression retarded tumor growth in mouse model. WISP2 downregulation enhanced cell growth, inhibited apoptosis, promoted cell migration and invasion in ESCC cells. Mechanistically, WISP2 exerts its tumor suppressive functions via regulation of ERK1/2, Slug, and E-cadherin in ESCC cells.

Conclusions: Our findings suggest that activation of WISP2 could be a useful therapeutic strategy for the treatment of ESCC.

Keywords: Esophageal cancer; Invasion; Migration; Proliferation; WISP2.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Antigens, CD / metabolism*
  • Biomarkers, Tumor / analysis
  • CCN Intercellular Signaling Proteins / metabolism*
  • Cadherins / metabolism*
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Cell Proliferation / physiology
  • Disease-Free Survival
  • Esophageal Neoplasms / metabolism*
  • Esophageal Neoplasms / pathology*
  • Esophageal Squamous Cell Carcinoma / metabolism
  • Esophageal Squamous Cell Carcinoma / pathology*
  • Female
  • Heterografts
  • Humans
  • MAP Kinase Signaling System / physiology*
  • Male
  • Mice
  • Mice, Nude
  • Middle Aged
  • Prognosis
  • Repressor Proteins / metabolism*

Substances

  • Antigens, CD
  • Biomarkers, Tumor
  • CCN Intercellular Signaling Proteins
  • CCN5 protein, human
  • CDH1 protein, human
  • Cadherins
  • Repressor Proteins